130 related articles for article (PubMed ID: 29501586)
1. PARP1 interacts with STAT3 and retains active phosphorylated-STAT3 in nucleus during pathological myocardial hypertrophy.
Wang L; Li Z; Tan Y; Li Q; Yang H; Wang P; Lu J; Liu P
Mol Cell Endocrinol; 2018 Oct; 474():137-150. PubMed ID: 29501586
[TBL] [Abstract][Full Text] [Related]
2. The poly(ADP-ribosyl)ation of FoxO3 mediated by PARP1 participates in isoproterenol-induced cardiac hypertrophy.
Lu J; Zhang R; Hong H; Yang Z; Sun D; Sun S; Guo X; Ye J; Li Z; Liu P
Biochim Biophys Acta; 2016 Dec; 1863(12):3027-3039. PubMed ID: 27686254
[TBL] [Abstract][Full Text] [Related]
3. PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy.
Li Q; Li ZM; Sun SY; Wang LP; Wang PX; Guo Z; Yang HW; Ye JT; Lu J; Liu PQ
Acta Pharmacol Sin; 2019 May; 40(5):589-598. PubMed ID: 30030529
[TBL] [Abstract][Full Text] [Related]
4. PKCζ interacts with STAT3 and promotes its activation in cardiomyocyte hypertrophy.
Li J; Gao H; Huang J; Wang P; Huang Y; Luo W; Zhang X; Shen P; You J; Cai S; Li Z; Liu P
J Pharmacol Sci; 2016 Sep; 132(1):15-23. PubMed ID: 27094369
[TBL] [Abstract][Full Text] [Related]
5. Transactivated EGFR mediates α₁-AR-induced STAT3 activation and cardiac hypertrophy.
Li Y; Zhang H; Liao W; Song Y; Ma X; Chen C; Lu Z; Li Z; Zhang Y
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1941-51. PubMed ID: 21856923
[TBL] [Abstract][Full Text] [Related]
6. STAT3 Suppression Is Involved in the Protective Effect of SIRT6 Against Cardiomyocyte Hypertrophy.
Zhang X; Li W; Shen P; Feng X; Yue Z; Lu J; You J; Li J; Gao H; Fang S; Li Z; Liu P
J Cardiovasc Pharmacol; 2016 Sep; 68(3):204-14. PubMed ID: 27124607
[TBL] [Abstract][Full Text] [Related]
7. Heat-shock transcription factor 1 is critically involved in the ischaemia-induced cardiac hypertrophy via JAK2/STAT3 pathway.
Yuan L; Qiu L; Ye Y; Wu J; Wang S; Wang X; Zhou N; Zou Y
J Cell Mol Med; 2018 Sep; 22(9):4292-4303. PubMed ID: 29992755
[TBL] [Abstract][Full Text] [Related]
8. Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway.
Fang X; Liu Y; Lu J; Hong H; Yuan J; Zhang Y; Wang P; Liu P; Ye J
Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1373-1385. PubMed ID: 30132020
[TBL] [Abstract][Full Text] [Related]
9. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
[TBL] [Abstract][Full Text] [Related]
11. Chrysophanol attenuated isoproterenol-induced cardiac hypertrophy by inhibiting Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway.
Yuan J; Hong H; Zhang Y; Lu J; Yu Y; Bi X; Wang J; Ye J
Cell Biol Int; 2019 Jun; 43(6):695-705. PubMed ID: 30977566
[TBL] [Abstract][Full Text] [Related]
12. ROS generated during early reperfusion contribute to intermittent hypobaric hypoxia-afforded cardioprotection against postischemia-induced Ca(2+) overload and contractile dysfunction via the JAK2/STAT3 pathway.
Wu L; Tan JL; Wang ZH; Chen YX; Gao L; Liu JL; Shi YH; Endoh M; Yang HT
J Mol Cell Cardiol; 2015 Apr; 81():150-61. PubMed ID: 25731682
[TBL] [Abstract][Full Text] [Related]
13. PARP1 Suppresses the Transcription of PD-L1 by Poly(ADP-Ribosyl)ating STAT3.
Ding L; Chen X; Xu X; Qian Y; Liang G; Yao F; Yao Z; Wu H; Zhang J; He Q; Yang B
Cancer Immunol Res; 2019 Jan; 7(1):136-149. PubMed ID: 30401677
[TBL] [Abstract][Full Text] [Related]
14. The cross-talk between PARylation and SUMOylation in C/EBPβ at K134 site participates in pathological cardiac hypertrophy.
Wang L; Wang P; Xu S; Li Z; Duan DD; Ye J; Li J; Ding Y; Zhang W; Lu J; Liu P
Int J Biol Sci; 2022; 18(2):783-799. PubMed ID: 35002525
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribose) polymerase 1 induces cardiac fibrosis by mediating mammalian target of rapamycin activity.
Sun S; Hu Y; Zheng Q; Guo Z; Sun D; Chen S; Zhang Y; Liu P; Lu J; Jiang J
J Cell Biochem; 2019 Apr; 120(4):4813-4826. PubMed ID: 29278652
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk between calcineurin/NFAT and Jak/STAT signalling induces cardioprotective alphaB-crystallin gene expression in response to hypertrophic stimuli.
Manukyan I; Galatioto J; Mascareno E; Bhaduri S; Siddiqui MA
J Cell Mol Med; 2010 Jun; 14(6B):1707-16. PubMed ID: 19538478
[TBL] [Abstract][Full Text] [Related]
17. Hypertrophic responses to cardiotrophin-1 are not mediated by STAT3, but via a MEK5-ERK5 pathway in cultured cardiomyocytes.
Takahashi N; Saito Y; Kuwahara K; Harada M; Tanimoto K; Nakagawa Y; Kawakami R; Nakanishi M; Yasuno S; Usami S; Yoshimura A; Nakao K
J Mol Cell Cardiol; 2005 Jan; 38(1):185-92. PubMed ID: 15623435
[TBL] [Abstract][Full Text] [Related]
18. PARP1 promote autophagy in cardiomyocytes via modulating FoxO3a transcription.
Wang C; Xu W; Zhang Y; Zhang F; Huang K
Cell Death Dis; 2018 Oct; 9(11):1047. PubMed ID: 30323296
[TBL] [Abstract][Full Text] [Related]
19. Opposing actions of extracellular signal-regulated kinase (ERK) and signal transducer and activator of transcription 3 (STAT3) in regulating microtubule stabilization during cardiac hypertrophy.
Ng DC; Ng IH; Yeap YY; Badrian B; Tsoutsman T; McMullen JR; Semsarian C; Bogoyevitch MA
J Biol Chem; 2011 Jan; 286(2):1576-87. PubMed ID: 21056972
[TBL] [Abstract][Full Text] [Related]
20. Role of nuclear unphosphorylated STAT3 in angiotensin II type 1 receptor-induced cardiac hypertrophy.
Yue H; Li W; Desnoyer R; Karnik SS
Cardiovasc Res; 2010 Jan; 85(1):90-9. PubMed ID: 19696070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
